Exploring barriers to optimal anticoagulation for atrial fibrillation: Interviews with clinicians

Journal of Multidisciplinary Healthcare

Volumn 5, Issue , 2012, Pages 129-135

  Decker, Carole ^a   Garavalia, Linda ^a   Garavalia, Brian ^a   Simon, Teresa ^b   Loeb, Matthew ^c   Spertus, John A ^e   Daniel, William C ^d  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c Bristol Myers Squibb ^*  (United States)

^d Cardiovascular Consultants Inc   (United States)

^e UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticoagulants; Atrial fibrillation; Risk factors

Indexed keywords

WARFARIN;

ANTICOAGULATION; ARTICLE; ATTITUDE TO HEALTH; CARDIOLOGIST; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CLINICAL DECISION MAKING; CONTENT ANALYSIS; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERDISCIPLINARY COMMUNICATION; INTERNIST; LIFESTYLE; MALE; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRESCRIPTION; PROPHYLAXIS; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW; SOCIAL ASPECT; SOCIAL STATUS; TREATMENT PLANNING;

EID: 84874772434     PISSN: None     EISSN: 11782390     Source Type: Journal    
DOI: 10.2147/JMDH.S33045     Document Type: Article

References (23)

1. Ingelgard A, Hollowell J, Prabashni R, Gold K, Tran K, Fitzmaurice D. What are the barriers to warfarin use in atrial fibrillation? Development of a questionnaire. J Thromb Thrombolysis. 2006;21:257-265.
2. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med. 2000;160:41-46.
3. Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM. Warfarin use in the elderly: the nurses' perspective. Aust J Adv Nurs. 2006;23:19-25.
4. Srivastava A, Hudson M, Hamoud I, Cavalcante J, Chetan P, Kaatz S. Examining warfarin underutilization rates in patients with atrial fibrillation: detailed chart review essential to capture contraindications to warfarin therapy. Thromb J. 2008;6:1-6.
5. Eagle KA, Cannom DS, Garcia DA. Management of atrial fibrillation: translating clinical trial data into clinical practice. Am J Med. 2011;124: 4-14.
6. Piccini JP, Patel MR, Mahaffey KW, Fox KAA, Califf RM. Rivaroxaban, an oral direct factor Xa inhibitor. Expert Opin Investig Drugs. 2008;17: 925-937.
7. Touchette DR, McGuinness ME, Stoner S, Shute D, Edwards JM, Ketchum K. Improving outpatient warfarin use for hospitalized patients with atrial fibrillation. Available at: http://www.pharmacypractice.org/vol06/01/043-050.htm. Accessed May 8, 2012.
8. Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GYH. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med. 2010;123:638-645.
9. Meinertz T, Kirch W, Rosin L, Pittrow D, Willich SN, Kirchhof P. Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol. 2011;100: 897-905.
10. Velu S, Lip GYH. What is the role of the cardiologist in future management of stroke prevention in atrial fibrillation? Adv Ther. 2011; 28:1-12.
11. Fuster V, Ryden LE, Cannom DS, etal. ACC/AHA/ESC 2006guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. Circulation. 2006;114:700-752.
12. Wann LS, Curtis AB, January CT, etal. 2011ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123:104-123.
13. Alonso-Coello P, Montori VM, Solà I, etal. Value and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study. BMC Health Serv Res. 2008:8;221.
14. Mavaddat N, Mant J. Primary care research and clinical practice: cardiovascular disease. Postgrad Med J. 2010;86:696-703.
15. Breakwell GM. Interviewing methods. In: Breakwell G, Hammond S, Fife-Schaw C, Smith J, editors. Research Methods in Psychology. 3rd ed. Los Angeles, CA: Sage Publications; 2006.
16. Garavalia L, Ho PM, Garavalia B, Foody etal. Clinician-patient discord: exploring differences in perspectives for discontinuing clopidogrel. Eur J Cardiovasc Nurs. 2011;10:50-55.
17. Patton M. Qualitative Evaluation and Research Methods. Thousand Oaks, CA: Sage Publications Inc; 2002.
18. Coffey A, Atkinson P. Making Sense of Qualitative Data. Thousand Oaks, CA: Sage Publications; 1996.
19. Denzin NK, Lincoln YS. Handbook of Qualitative Research. 3rd ed. Thousand Oaks, CA: Sage Publications; 2005.
20. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277-1288.
21. Creswell JW. Qualitative Inquiry and Research Design: Choosing Among Five Traditions. 2nd ed. Thousand Oaks, CA: Sage Publications; 2003.
22. Marshall C, Rossman GB. Designing Qualitative Research. 3rd ed. Thousand Oaks, CA: Sage Publications; 2006.
23. Rose AJ. Patient education: the missing link in improving quality of oral anticoagulation. Cardiology. 2010;116:59-60.